Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia

NCT00028847 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: imatinib mesylate

Sponsor

Commissie Voor Klinisch Toegepast Onderzoek